AIB1 predicts tumor response to definitive chemoradiotherapy and prognosis in cervical squamous cell carcinoma

Amplified in breast cancer 1 (AIB1) gene, has been reported to be associated with biological malignancy in several cancers. However, the molecular status of the AIB1 gene in cervical cancer and the clinicopathological/prognostic significance of AIB1 expression in chemoradiotherapy (CRT) sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhenfeng, Zhou, Shuguang, Li, Wenyu, Zhong, Fei, Zhang, Heping, Sheng, Lei, Li, Yue, Xu, Meng, Xu, Jifei, Zhan, Lei, Li, Bao, Wang, Fan, Xie, Dan, Tong, Zhuting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775615/
https://www.ncbi.nlm.nih.gov/pubmed/31602272
http://dx.doi.org/10.7150/jca.31697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775615/
https://www.ncbi.nlm.nih.gov/pubmed/31602272
http://dx.doi.org/10.7150/jca.31697

Ejemplares similares